The following is an excerpt from an article published in the Wall Street Journal on Saturday: (read full article, click here.):
“A prominent Emory University psychiatrist failed to tell the school about $500,000 he received from drug maker GlaxoSmithKline PLC while heading a government-funded research project studying Glaxo drugs, Sen. Charles Grassley alleged.
The payments to Charles Nemeroff, chairman of the Atlanta university’s psychiatry department, compensated him for making presentations to doctors about Glaxo drugs, including its big-selling antidepressant Paxil, according to records Sen. Grassley obtained from Emory and Glaxo. The senator made the allegations in a letter to Emory President James W. Wagner dated Thursday….
In correspondence with Emory officials who police conflict-of-interest issues, Dr. Nemeroff repeatedly denied having a significant financial relationship with Glaxo, according to the records cited by Sen. Grassley, an Iowa Republican who has been investigating ties between academic researchers and the medical industry.
Federally sponsored research, including work Dr. Nemeroff did, is supposed to be free of financial conflicts, but enforcement is generally left to universities, which seldom act against prominent researchers. Emory instructed Dr. Nemeroff not to take more than $10,000 a year from Glaxo — its conflicts threshold — but he exceeded that amount, Sen. Grassley said.
From 2000 through 2006, Dr. Nemeroff received just over $960,000 from Glaxo, but reported to Emory that he received no more than $35,000, the letter said.”
Filed under: Tennessee | Tagged: anti-depressant drug, Anti-Depressants, Big Pharma, conflict of interest, deception for pay, Dr. Charles Nemeroff, Emory President James W. Wagner, Emory psychiatrist, Emory University, flase PR for Paxil, GlaxoSmithKline, Iowa Senator Charles Grassley, love of money is root of evil, misleading drug claims for money, paid spokesman for Paxil, paxil's false claims, Pharmaceuticals Companies
